B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection

Kuan-Hsiang G Huang, David Bonsall, Aris Katzourakis, Emma C Thomson, Sarah J Fidler, Janice Main, David Muir, Jonathan N Weber, Alexander J Frater, Rodney E Phillips, Oliver G Pybus, Philip JR Goulder, Myra O McClure, Graham S Cooke, Paul Klenerman
2010-10-19
Abstract:HIV can be partially contained by host immunity and understanding the basis of this may inform vaccine design. The importance of B-cell function in long-term control is poorly understood. One method of investigating this is in vivo cellular depletion. In this study, we take advantage of a unique opportunity to investigate the role of B cells in an HIV-infected patient. The HIV-1+ patient studied here was not taking antiretroviral drugs and was treated for pre-existing low-grade lymphoplasmacytoid lymphoma by depletion of CD20+ B cells using rituximab. We demonstrate that B-cell depletion results in a decline in autologous neutralizing antibody (NAb) responses and a 1.7 log10 rise in HIV-1 plasma viral load (pVL). The recovery of NAbs results in a decline in pVL. The HIV-1 sequences diversify and NAb-resistant mutants are subsequently selected. These data suggest that B-cell function can contribute to the long-term …
What problem does this paper attempt to address?